Chen L C, Sly L, Jones C S, Tarone R, De Luca L M
Differentiation Control Section, National Cancer Institute, Bethesda, MD.
Carcinogenesis. 1993 Apr;14(4):713-7. doi: 10.1093/carcin/14.4.713.
SENCAR mice were used to determine the effects of the provitamin A compound beta-carotene on papilloma formation and the conversion of papillomas to carcinomas in a two-stage protocol with one application of the initiator 7,12-dimethylbenz[a]anthracene (DMBA, 20 micrograms) and 20 weekly applications of the promotor 12-O-tetradecanoylphorbol-13-acetate (TPA, 2 micrograms). A purified vitamin A-free diet was supplemented with beta-carotene at four levels (0.6, 6, 60 and 600 micrograms/g of diet) for female mice and two levels (60 and 600 micrograms/g) for male mice. Dietary supplementations of beta-carotene did not result in significant changes in body weight and survival of female and male mice. However, papillomas developed more rapidly and papilloma incidence (% mice with papillomas) reached its maximum (100%) sooner in male mice fed 600 micrograms of beta-carotene/g of diet than those fed 60 micrograms/g. There were smaller differences in papilloma incidence among the dietary groups in female mice, but the papilloma incidence again reached 100% sooner in mice fed 600 micrograms of beta-carotene/g of diet. Female and male mice fed 600 micrograms of beta-carotene/g of diet had significantly higher papilloma yields (average number of papillomas/mouse) than other dietary groups and a very low percentage of these papillomas converted to carcinomas in these mice. Thus, beta-carotene at 600 micrograms/g inhibited the conversion of papillomas to carcinomas in both sexes. In addition, papilloma yields were higher in female mice and these papillomas regressed more quickly than those in the corresponding groups of male mice. In conclusion, dietary beta-carotene caused differential effects on papilloma and carcinoma yields and sex-dependent differences in papilloma formation in female and male SENCAR mice treated with DMBA and TPA in a two-stage carcinogenesis protocol.
在两阶段实验方案中,使用SENCAR小鼠来确定维生素A原化合物β-胡萝卜素对乳头状瘤形成以及乳头状瘤向癌转化的影响。该方案包括一次涂抹引发剂7,12-二甲基苯并[a]蒽(DMBA,20微克)和每周20次涂抹促进剂12-O-十四烷酰佛波醇-13-乙酸酯(TPA,2微克)。给雌性小鼠提供添加了四个水平(0.6、6、60和600微克/克饲料)β-胡萝卜素的纯化无维生素A饲料,给雄性小鼠提供添加了两个水平(60和600微克/克)β-胡萝卜素的饲料。饮食中补充β-胡萝卜素对雌性和雄性小鼠的体重和存活率没有显著影响。然而,在喂食600微克β-胡萝卜素/克饲料的雄性小鼠中,乳头状瘤生长更快,乳头状瘤发生率(患乳头状瘤的小鼠百分比)比喂食60微克/克的雄性小鼠更快达到最大值(100%)。雌性小鼠不同饮食组之间乳头状瘤发生率的差异较小,但喂食600微克β-胡萝卜素/克饲料的小鼠中乳头状瘤发生率同样更快达到100%。喂食600微克β-胡萝卜素/克饲料的雌性和雄性小鼠的乳头状瘤产量(每只小鼠乳头状瘤的平均数量)显著高于其他饮食组,并且这些小鼠中乳头状瘤转化为癌的比例非常低。因此,600微克/克的β-胡萝卜素抑制了两性中乳头状瘤向癌的转化。此外,雌性小鼠的乳头状瘤产量更高,并且这些乳头状瘤比相应雄性小鼠组中的乳头状瘤消退得更快。总之,在两阶段致癌实验方案中,用DMBA和TPA处理的雌性和雄性SENCAR小鼠,饮食中的β-胡萝卜素对乳头状瘤和癌的产量产生了不同影响,并且在乳头状瘤形成方面存在性别差异。